<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter" xml:lang="es"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Clin (Barc)</journal-id><journal-id journal-id-type="iso-abbrev">Med Clin (Barc)</journal-id><journal-title-group><journal-title>Medicina Clinica</journal-title></journal-title-group><issn pub-type="ppub">0025-7753</issn><issn pub-type="epub">1578-8989</issn><publisher><publisher-name>Elsevier Espa&#x000f1;a, S.L.U.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7274618</article-id><article-id pub-id-type="publisher-id">S0025-7753(20)30342-0</article-id><article-id pub-id-type="doi">10.1016/j.medcli.2020.05.015</article-id><article-categories><subj-group subj-group-type="heading"><subject>Carta al Editor</subject></subj-group></article-categories><title-group><article-title>Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>One world, one health: The novel coronavirus COVID-19 epidemic</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Callejas Rubio</surname><given-names>Jos&#x000e9; Luis</given-names></name><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>R&#x000ed;os Fern&#x000e1;ndez</surname><given-names>Raquel</given-names></name></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Ortego Centeno</surname><given-names>Norberto</given-names></name></contrib><aff id="aff0005">Unidad de Enfermedades Sist&#x000e9;micas, Servicio de Medicina Interna, Hospital San Cecilio, Granada, Espa&#x000f1;a</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Autor para correspondencia.</corresp></author-notes><pub-date pub-type="pmc-release"><day>5</day><month>6</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><day>25</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>5</day><month>6</month><year>2020</year></pub-date><volume>155</volume><issue>6</issue><fpage>272</fpage><lpage>272</lpage><permissions><copyright-statement>&#x000a9; 2020 Elsevier Espa&#x000f1;a, S.L.U. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Elsevier Espa&#x000f1;a, S.L.U.</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><body><p content-type="salutation"><italic>Sr. Editor:</italic></p><p id="par0005">Hemos le&#x000ed;do el magn&#x000ed;fico editorial recientemente publicado en su revista por Trilla A, sobre la epidemia por coronavirus COVID-19<xref rid="bib0030" ref-type="bibr"><sup>1</sup></xref>. Entendemos que la intenci&#x000f3;n del autor, como especialista en medicina preventiva y epidemiolog&#x000ed;a, no ha sido revisar los diferentes aspectos cl&#x000ed;nicos de la infecci&#x000f3;n por SARS-CoV-2, de lo que estamos seguros tiempo habr&#x000e1; para rellenar hojas y hojas en los pr&#x000f3;ximos meses en esta prestigiosa publicaci&#x000f3;n, ni los diferentes tratamientos empleados. Pero lo que se puede deducir de su lectura, sobre todo por lectores alejados del diagn&#x000f3;stico, seguimiento cl&#x000ed;nico y tratamiento de esta enfermedad, es que se trata de una enfermedad meramente infecciosa, que produce b&#x000e1;sicamente un cuadro viral que se puede complicar con una neumon&#x000ed;a m&#x000e1;s o menos grave con distr&#x000e9;s, y cuyo tratamiento se sustenta en el uso de f&#x000e1;rmacos antivirales. Nada m&#x000e1;s alejado de la pura realidad. Desde el punto de vista cl&#x000ed;nico las manifestaciones cl&#x000ed;nicas pueden ser muy diversas, afectando pr&#x000e1;cticamente cualquier aparato, sistema u &#x000f3;rgano de nuestra econom&#x000ed;a<xref rid="bib0035" ref-type="bibr">2</xref>, <xref rid="bib0040" ref-type="bibr">3</xref>, <xref rid="bib0045" ref-type="bibr">4</xref>. Desde el punto de vista terap&#x000e9;utico, y con idea de frenar otra muy grave complicaci&#x000f3;n de esta infecci&#x000f3;n, como es el s&#x000ed;ndrome de tormenta de citoquinas, junto al uso de antivirales es fundamental el uso de f&#x000e1;rmacos inmunomoduladores e inmunodepresores<xref rid="bib0050" ref-type="bibr"><sup>5</sup></xref>.</p><p id="par0010">Por tanto, la infecci&#x000f3;n por SARS-CoV-2 representa, en nuestra opini&#x000f3;n, el paradigma de una enfermedad sist&#x000e9;mica, con un desencadenante infeccioso, en este caso el virus, y una respuesta inmunol&#x000f3;gica con manifestaciones sist&#x000e9;micas, que requiere del uso de un tratamiento inmunosupresor.</p></body><back><ref-list id="bibl0005"><title>Bibliograf&#x000ed;a</title><ref id="bib0030"><label>1</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Trilla</surname><given-names>A.</given-names></name></person-group><article-title>One world, one health: The novel coronavirus COVID-19 epidemic</article-title><source>Med Clin (Engl Ed)</source><volume>154</volume><year>2020</year><fpage>175</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.medcle.2020.02.001</pub-id><pub-id pub-id-type="pmid">32289080</pub-id></element-citation></ref><ref id="bib0035"><label>2</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name></person-group><article-title>Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China</article-title><source>JAMA Neurol</source><year>2020</year><fpage>e201127</fpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2020.1127</pub-id></element-citation></ref><ref id="bib0040"><label>3</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Duan</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Spiegel</surname><given-names>B.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name></person-group><article-title>Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation Stool Viral RNA Testing, and Outcomes</article-title><source>Am J Gastroenterol</source><year>2020</year><pub-id pub-id-type="doi">10.14309/ajg.0000000000000664</pub-id></element-citation></ref><ref id="bib0045"><label>4</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Guzik</surname><given-names>T.J.</given-names></name><name><surname>Mohiddin</surname><given-names>S.A.</given-names></name><name><surname>Dimarco</surname><given-names>A.</given-names></name><name><surname>Patel</surname><given-names>V.</given-names></name><name><surname>Savvatis</surname><given-names>K.</given-names></name><name><surname>Marelli-Berg</surname><given-names>F.M.</given-names></name></person-group><article-title>COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options</article-title><source>Cardiovasc Res</source><year>2020</year><pub-id pub-id-type="doi">10.1093/cvr/cvaa106</pub-id></element-citation></ref><ref id="bib0050"><label>5</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Alijotas-Reig</surname><given-names>J.</given-names></name><name><surname>Esteve-Valverde</surname><given-names>E.</given-names></name><name><surname>Belizna</surname><given-names>C.</given-names></name><name><surname>Selva-O&#x02019;Callaghan</surname><given-names>A.</given-names></name><name><surname>Pardos-Gea</surname><given-names>J.</given-names></name><name><surname>Quintana</surname><given-names>A.</given-names></name></person-group><article-title>Immunomodulatory therapy for the management of severe COVID-19 Beyond the anti-viral therapy: A comprehensive review</article-title><source>Autoimmun Rev</source><year>2020</year><fpage>102569</fpage><pub-id pub-id-type="doi">10.1016/j.autrev.2020.102569</pub-id><pub-id pub-id-type="pmid">32376394</pub-id></element-citation></ref></ref-list></back></article>